Please assess the completion status of the following clinical trial:

Trial Title: PoCUS Guided Fluids to Prevent Post-induction Hypotension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-70 years~* Elective surgery~* IVC-CI ≥ 43% on their preoperative POCUS scan.~Exclusion Criteria:~* Hypotension, defined as MAP below 65 mmhg, prior to the induction of general anesthesia.~* Treated with angiotensin converting enzyme inhibitors (ACE-I) or angiotensin receptor blockers (ARB) on the day of surgery.~* Patients with heart failure with ejection fraction (EF) \< 40%.~* Patients with documented acute or chronic renal failure.~* Patients with neuraxial blockade (epidural or spinal) performed before induction of general anesthesia.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Fluid Bolus (FB+) (Type: ACTIVE_COMPARATOR): Patients in the FB+ group will receive a single bolus of 500 ml of Ringer's Lactate over 5-10 minutes.
- Non fluid bolus (FB-) (Type: PLACEBO_COMPARATOR): Patients in the FB- group will not receive a fluid bolus.

Based on this trial design, predict the completion outcome and termination type (if applicable).